ஹரால்ட் மறுஹார்ட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Globe Newswire. The AP news staff was not involved in its creation.
argenx and Zai Lab Announce Strategic Collaboration for Efgartigimod in Greater China
Zai Lab Limited; argenxJanuary 6, 2021 GMT
Collaboration to expand and accelerate global development of efgartigimod; expected to allow argenx to more rapidly advance new potential indications into clinical development each year
Zai Lab granted exclusive rights to develop and commercialize efgartigimod in Greater China
argenx to receive $75 million in upfront Zai Lab equity and $100 million in near-term milestone and other payments
Regulated Information/Inside Information
BREDA, the Netherlands and SHANGHAI and SAN FRANCISCO, Jan. 06, 2021 (GLOBE NEWSWIRE) argenx SE (Euronext & NASDAQ: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, and Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an inno ....

United States , Hong Kong , Mike Zanoni , Billy Cho , Ryo Imai Robert Flamm , Harald Reinhart , Dburns Mcclellan , Kelsey Kirk , Beth Delgiacco , Tim Van Hauwermeiren , Zai Lab Contacts , Zai Lab , Zai Lab Limited , Immunology Innovation Program , Greater China , Chief Executive Officer , Chief Medical Officer , Infectious Diseases , Ryo Imai , Robert Flamm , ஒன்றுபட்டது மாநிலங்களில் , ஹாங் காங் , மைக் ஜஞோநி , பில்லி சோ , ஹரால்ட் மறுஹார்ட் , தீக்காயங்கள் ம்க்க்லெல்யாந் ,